StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) income statement

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.08−0.02 (-0.95%)

Close on Nov 18, 2026Market cap $113.92MP/E –Yield –

Upstream Bio, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-6116.0%
Net margin
-5712.3%
Return on equity, FY2025
-35.4%

Financial strength

Current ratio
20.45
Debt to equity
–
Debt to assets
–
Cash to current liabilities
396.5%

Valuation

P/E ratio
–
Price to sales
39.69
Price to book
0.49
Dividend yield
–

See a number that looks wrong?